deCODE genetics, Inc., Multinational Research Team Find Gene Variant Conferring High Risk for Common, Late-Onset Form of Alzheimer’s Disease

REYKJAVIK, Iceland--(BUSINESS WIRE)--deCODE Genetics and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and collaborators from Holland, Germany and the United States, reported today in the New England Journal of Medicine the identification of just the second gene variant found to confer high risk of acquiring the more common, late-onset form of Alzheimer’s disease. The newly discovered variant was also found to predict poorer cognitive function in older individuals who do not have Alzheimer’s disease.